Biointelect Overview
- Founded
-
2011
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
Biointelect General Information
Description
Provider of biopharmaceutical consulting services intended to develop and drive strategy. The company's services conduct detailed market evaluations and define optimum clinical, regulatory, reimbursement and market-entry strategies, enabling clients to identify opportunities and reduce risk as well as optimize commercial results for their bio-pharmaceutical product or medical device.
Contact Information
Website
www.biointelect.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Services
Other Industries
Consulting Services (B2B)
Biotechnology
Primary Office
- 139 Macquarie Street
- Suite 5.02, Level 5
- Sydney, New South Wales 2000
- Australia
+61 1300 000 000
Biointelect Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biointelect Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Max Howell | Chief Financial Officer | ||
| Jennifer Herz | Managing Director & Founder | ||
| Trina Thompson | Finance Manager |
Biointelect Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 00000000 | Biointelect | Chairman & Advisor | 000 0000 |
| 0000 0000 | Biointelect | Board Member | 000 0000 |
Biointelect Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Biointelect Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|